ITRM20050090A1 - Derivati dell'acido ammino-butanoico inibitore della cpt. - Google Patents

Derivati dell'acido ammino-butanoico inibitore della cpt.

Info

Publication number
ITRM20050090A1
ITRM20050090A1 IT000090A ITRM20050090A ITRM20050090A1 IT RM20050090 A1 ITRM20050090 A1 IT RM20050090A1 IT 000090 A IT000090 A IT 000090A IT RM20050090 A ITRM20050090 A IT RM20050090A IT RM20050090 A1 ITRM20050090 A1 IT RM20050090A1
Authority
IT
Italy
Prior art keywords
cpt
derivatives
amino
butanoic acid
acid inhibitor
Prior art date
Application number
IT000090A
Other languages
English (en)
Italian (it)
Inventor
Roberto Conti
Uomo Natalina Dell
Fabio Giannessi
Emanuela Tassoni
Maria Ornella Tinti
Original Assignee
Sigma Tau Ind Farmaceutiche Riunite Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceutiche Riunite Spa filed Critical Sigma Tau Ind Farmaceutiche Riunite Spa
Priority to IT000090A priority Critical patent/ITRM20050090A1/it
Priority to CA002599165A priority patent/CA2599165A1/en
Priority to MX2007009007A priority patent/MX2007009007A/es
Priority to SG201001512-1A priority patent/SG159569A1/en
Priority to EA200701868A priority patent/EA200701868A1/ru
Priority to JP2007557357A priority patent/JP2008531613A/ja
Priority to US11/815,068 priority patent/US20080161395A1/en
Priority to AU2006220097A priority patent/AU2006220097B2/en
Priority to EP06706901A priority patent/EP1853556A1/en
Priority to BRPI0607558-4A priority patent/BRPI0607558A2/pt
Priority to PCT/EP2006/001290 priority patent/WO2006092204A1/en
Priority to KR1020077022098A priority patent/KR20070114197A/ko
Priority to CNA2006800065461A priority patent/CN101133019A/zh
Priority to TW095105107A priority patent/TW200640842A/zh
Priority to ARP060100732A priority patent/AR052677A1/es
Publication of ITRM20050090A1 publication Critical patent/ITRM20050090A1/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/04—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms
    • C07C275/06—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms of an acyclic and saturated carbon skeleton
    • C07C275/16—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms of an acyclic and saturated carbon skeleton being further substituted by carboxyl groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • C07D213/82—Amides; Imides in position 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Cardiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
IT000090A 2005-03-02 2005-03-02 Derivati dell'acido ammino-butanoico inibitore della cpt. ITRM20050090A1 (it)

Priority Applications (15)

Application Number Priority Date Filing Date Title
IT000090A ITRM20050090A1 (it) 2005-03-02 2005-03-02 Derivati dell'acido ammino-butanoico inibitore della cpt.
CA002599165A CA2599165A1 (en) 2005-03-02 2006-02-13 Derivatives of aminobutanoic acid inhibiting cpt
MX2007009007A MX2007009007A (es) 2005-03-02 2006-02-13 Derivados de acido aminobutanoico que inhiben carnitina palmitoil transferasa.
SG201001512-1A SG159569A1 (en) 2005-03-02 2006-02-13 Derivatives of aminobutanoic acid inhibiting cpt
EA200701868A EA200701868A1 (ru) 2005-03-02 2006-02-13 Производные аминобутановой кислоты, ингибирующие cpt
JP2007557357A JP2008531613A (ja) 2005-03-02 2006-02-13 Cptを阻害するアミノブタン酸誘導体
US11/815,068 US20080161395A1 (en) 2005-03-02 2006-02-13 Derivatives of Aminobutanoic Acid Inhibiting Cpt
AU2006220097A AU2006220097B2 (en) 2005-03-02 2006-02-13 Derivatives of aminobutanoic acid inhibiting CPT
EP06706901A EP1853556A1 (en) 2005-03-02 2006-02-13 Derivatives of aminobutanoic acid inhibiting cpt
BRPI0607558-4A BRPI0607558A2 (pt) 2005-03-02 2006-02-13 derivados do ácido aminobutanóico, inibidor da carnitina palmitoil transferase(cpt)
PCT/EP2006/001290 WO2006092204A1 (en) 2005-03-02 2006-02-13 Derivatives of aminobutanoic acid inhibiting cpt
KR1020077022098A KR20070114197A (ko) 2005-03-02 2006-02-13 씨피티를 억제하는 아미노부탄산의 유도체
CNA2006800065461A CN101133019A (zh) 2005-03-02 2006-02-13 抑制cpt的氨基丁酸衍生物
TW095105107A TW200640842A (en) 2005-03-02 2006-02-15 Derivatives of aminobutanoic acid inhibiting CPT
ARP060100732A AR052677A1 (es) 2005-03-02 2006-02-28 Compuesto en la forma racemica (r,s) o en sus formas enantiomericas r y s y sus sales farmacologicamente aceptables

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT000090A ITRM20050090A1 (it) 2005-03-02 2005-03-02 Derivati dell'acido ammino-butanoico inibitore della cpt.

Publications (1)

Publication Number Publication Date
ITRM20050090A1 true ITRM20050090A1 (it) 2006-09-03

Family

ID=36090946

Family Applications (1)

Application Number Title Priority Date Filing Date
IT000090A ITRM20050090A1 (it) 2005-03-02 2005-03-02 Derivati dell'acido ammino-butanoico inibitore della cpt.

Country Status (15)

Country Link
US (1) US20080161395A1 (enExample)
EP (1) EP1853556A1 (enExample)
JP (1) JP2008531613A (enExample)
KR (1) KR20070114197A (enExample)
CN (1) CN101133019A (enExample)
AR (1) AR052677A1 (enExample)
AU (1) AU2006220097B2 (enExample)
BR (1) BRPI0607558A2 (enExample)
CA (1) CA2599165A1 (enExample)
EA (1) EA200701868A1 (enExample)
IT (1) ITRM20050090A1 (enExample)
MX (1) MX2007009007A (enExample)
SG (1) SG159569A1 (enExample)
TW (1) TW200640842A (enExample)
WO (1) WO2006092204A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3144493A1 (en) * 2006-10-03 2008-04-10 Arbutus Biopharma Corporation Lipid containing formulations
CA2680366C (en) * 2007-03-09 2016-06-21 University Health Network Inhibitors of carnitine palmitoyltransferase and treating cancer
WO2009015485A1 (en) 2007-08-01 2009-02-05 University Health Network Cyclic inhibitors of carnitine palmitoyltransferase and treating cancer
WO2009132978A1 (en) * 2008-04-29 2009-11-05 F. Hoffmann-La Roche Ag 4-dimethylaminobutyric acid derivatives
CA2722114A1 (en) 2008-04-29 2009-11-05 F. Hoffmann-La Roche Ag 4-trimethylammonio-butyrates as cpt2 inhibitors
KR20230041744A (ko) * 2020-07-17 2023-03-24 사노피 파스퇴르 화학식 -nh-cx-a 또는 -nh-cx-nh-a의 적어도 하나의 말단 라디칼을 포함하는 지질 화합물, 이를 포함하는 조성물 및 이의 용도

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1299266B1 (it) * 1998-05-15 2000-02-29 Sigma Tau Ind Farmaceuti Inibitori reversibili della carnitina palmitoil trasferasi
US6822115B2 (en) * 1999-06-30 2004-11-23 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Synthesis of (R) and (S)-aminocarnitine, (R) and (S)-4-phosphonium-3-amino-butanoate, (R) and (S) 3,4-diaminobutanoic acid, and their derivatives starting from D- and L-aspartic acid
CA2680366C (en) 2007-03-09 2016-06-21 University Health Network Inhibitors of carnitine palmitoyltransferase and treating cancer

Also Published As

Publication number Publication date
BRPI0607558A2 (pt) 2009-09-15
KR20070114197A (ko) 2007-11-29
CN101133019A (zh) 2008-02-27
JP2008531613A (ja) 2008-08-14
CA2599165A1 (en) 2006-09-08
AU2006220097A1 (en) 2006-09-08
US20080161395A1 (en) 2008-07-03
MX2007009007A (es) 2007-09-14
EP1853556A1 (en) 2007-11-14
AR052677A1 (es) 2007-03-28
EA200701868A1 (ru) 2008-02-28
TW200640842A (en) 2006-12-01
AU2006220097B2 (en) 2011-07-07
WO2006092204A1 (en) 2006-09-08
SG159569A1 (en) 2010-03-30

Similar Documents

Publication Publication Date Title
PL1636190T3 (pl) Trwały kryształ związku 4-oksochinoliny
DK1660431T3 (da) Phenoxyeddikesyrederivater
EP1834400A4 (en) NANOMECHANICAL OSCILLATOR
EP1976511A4 (en) FLUORATED ARYLAMIDE DERIVATIVES
WO2007015017A3 (fr) Nouveaux derives de polyquinoleines et leur utilisation therapeutique
IS7453A (is) Trópan afleiður sem CCR5 stillar
EP1839669A4 (en) NEW ANGIOGENESEHEMMER
ATE396724T1 (de) 1h-thieno 2,3-c-pyrazol-derivate als kinase-i- hemmer
UY3668Q (es) Reloj pulsera&#34;balloon&#34;
CY2011018I1 (el) Νεα κρυσταλλικη μορφη toy 8-kyan-1-kykλoπpoπyλ-7-(1s,6s-2,8-διαζαδικυκλο[4.3.0]εννεαν-8-υλ)-6-φθορο-1,4-διυδρο-4-οξο-3-κινολινο-καρβοξυλικου οξεος
DE60236403D1 (de) Tourbillonmechanismus
DE502005005664D1 (de) Chronograph
ITFI20050041A1 (it) Idrossammati come inibitori dell&#39;istone deacelitasi, loro preparazione e formulazioni farmaceutiche che li contengono
NL1032046A1 (nl) Prostaglandinederivaten.
EP1910272A4 (en) Renin Inhibitors
UY3556Q (es) Reloj brazalete
DE602006014973D1 (de) Neuartige cercosporamidderivate
DE602005006734D1 (de) Uhrwerk
FI20055672L (fi) Sauvan tassu
EP1753416A4 (en) MORONIC ACID DERIVATIVES USED AGAINST RETROVIRUSES
EP1921139A4 (en) Novel endoribonuclease
EP1921138A4 (en) NEW ENDORIBONUCLEASE
DK1833814T3 (da) Fremgangsmåde til fremstilling af substituerede 2-alkoxycarbonyl-3-aminothiophener
DK1735297T3 (da) Fremgangsmåde til fremstilling af benzoxathiepinderivater
ITMI20041206A1 (it) Derivati benzazinici inibitori della fosfodiesterasi 4